Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118404) titled 'First in Human study of FixTA Endovasular Stentgraft for Aortic arch' on Feb. 5.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

Condition: aortic dissection, aortic pseudoaneurysm, aortic rupture

Recruitment Status: Recruiting

Phase: 0

Date of First Enrollment: 2024-04-17

Target Sample Size: Test group:102;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=294110

Disclaimer: Curated by HT Syndication....